Exposure to ganciclovir with oral valganciclovir exceeds that of oral ganciclovir

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1487, 2005-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of Valganciclovir and Ganciclovir Following Multiple Oral Dosages of Valganciclovir in HIV- and CMV-Seropositive Volunteers

By Brown F.  

Clinical Pharmacokinetics, Vol. 37, Iss. 2, 1999-08 ,pp. : 167-176

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Profile of Ganciclovir After its Oral Administration and From its Prodrug, Valganciclovir, in Solid Organ Transplant Recipients

By Wiltshire Hugh  

Clinical Pharmacokinetics, Vol. 44, Iss. 5, 2005-01 ,pp. : 495-507

Adis International

Access to resources Recommend Favorite

Valganciclovir: once-daily alternative to ganciclovir for CMV

By  

Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Ganciclovir/valganciclovir: Neutrophil dysplasia: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1071, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS

By Rachlis A.  

PharmacoEconomics, Vol. 16, Iss. 1, 1999-07 ,pp. : 71-84

Adis International

Access to resources Recommend Favorite